Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PALXPalomino Laboratories Inc.

OTC · CIK 0001938569
Filer category<br>Emerging growth company
Entity typeoperating
SIC3674 Semiconductors & Related Devices
FY end1231
XBRL facts182

Identity from submissions API

NamePalomino Laboratories Inc.
CIK0001938569
TickersPALX
ExchangesOTC
Entity typeoperating
Category<br>Emerging growth company
SIC3674 Semiconductors & Related Devices
EIN881619619
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(917) 200-3734
Website—
Investor website—
Owner org04 Manufacturing
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Unite Acquisition 3 Corp. (2023-08-10T00:00:00.000Z → 2025-08-29T00:00:00.000Z)
Business address
130 CASTILIAN DRIVE
SUITE 102
GOLETA
CA
93117
CA
Mailing address
130 CASTILIAN DRIVE
SUITE 102
GOLETA
CA
93117
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

54 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001493152-26-051777 000-56582 261553530 34 5390259 1 1
2026-11-06 8-K 8-K 5.07,9.01 0001493152-26-050300 000-56582 261528892 34 222757 1 1
2026-10-14 8-K/A 8-K/A 9.01 0001493152-26-046955 000-56582 261459098 34 661122 1 1
2026-10-08 DEF 14A DEF 14A 0001493152-26-046296 000-56582 261449259 34 527327 1 1
2026-09-28 PRE 14A PRE 14A 0001493152-26-044402 000-56582 261411421 34 260333
2026-08-21 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-039653 005-95213 261304532 34 8887
2026-08-05 8-K 8-K 1.01,2.01,7.01,9.01 0001493152-26-036127 000-56582 261241985 34 543748 1 1
2026-08-05 10-Q 10-Q 0001493152-26-036061 000-56582 261240635 34 4264691 1 1
2026-08-04 4 4 0001493152-26-035982 5615
2026-07-16 8-K 8-K 1.01,7.01,9.01 0001493152-26-033505 000-56582 261180311 34 330658 1 1
2026-05-15 10-Q 10-Q 0001493152-26-023678 000-56582 26986428 34 3547417 1 1
2026-05-05 8-K 8-K 3.02,9.01 0001493152-26-021282 000-56582 26942206 34 347179 1 1
2026-05-01 D xslFormDX01/primary_doc.xml 06b 0001493152-26-020909 021-582648 26933470 33 9504
2026-04-24 8-K 8-K 1.01,3.02,9.01 0001493152-26-018963 000-56582 26895714 34 1319891 1 1
2026-04-20 4 4 0001493152-26-018119 4746
2026-04-20 4 4 0001493152-26-018116 4714
2026-04-09 8-K 8-K 8.01 0001493152-26-015767 000-56582 26849569 34 191355 1 1
2026-03-31 10-K 10-K 0001493152-26-014270 000-56582 26823027 34 47340792 1 1
2026-02-12 424B3 424B3 0001493152-26-006261 333-292890 26622391 33 1395813
2026-02-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000481 333-292890 26613323 33 1859
2026-02-05 CORRESP filename1.htm 0001493152-26-005427 11735
2026-01-23 S-1 S-1 0001493152-26-003287 333-292890 26553054 33 23792492 1 1
2026-01-13 UPLOAD filename1.pdf 0000000000-26-000443 377-08931 40705
2026-01-12 DRS filename1.htm 0001493152-26-001169 377-08931 26524376 33 18587222
2025-11-14 10-Q 10-Q 0001493152-25-023285 000-56582 251484239 34 4067353 1 1
2025-10-30 8-K 8-K 3.02,9.01 0001493152-25-020229 000-56582 251435865 34 977542 1 1
2025-10-27 4 4 0001493152-25-019755 7962
2025-10-27 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-019712 005-95213 251419454 34 11368
2025-10-14 D xslFormDX01/primary_doc.xml 06b 0001493152-25-017841 021-560582 251388933 33 10450
2025-10-09 4 4 0001493152-25-017607 7794
2025-10-09 4 4 0001493152-25-017571 7852
2025-10-09 4 4 0001493152-25-017568 7807
2025-10-08 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-017501 005-95213 251383505 34 11222
2025-10-07 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-017262 005-95213 251379319 34 11175
2025-10-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-096685 005-95213 251377844 34 9853
2025-10-06 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-096683 005-95213 251377841 34 17029
2025-10-06 8-K 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,9.01 0001493152-25-016939 000-56582 251375104 34 7595290 1 1
2025-10-02 4 xslF345X05/ownership.xml 0001213900-25-095630 5505
2025-08-29 SC 14F1 SCHEDULE 14F-1 0001213900-25-082560 005-95213 251280801 34 102943
2025-08-07 10-Q QUARTERLY REPORT 0001213900-25-073079 000-56582 251194045 34 1897624 1 1
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044348 000-56582 25955113 34 1640200 1 1
2025-03-28 10-K ANNUAL REPORT 0001013762-25-004263 000-56582 25787929 34 2222984 1 1
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098466 000-56582 241462728 34 1544366 1 1
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068823 000-56582 241206253 34 1478248 1 1
2024-05-15 10-Q QUARTERLY REPORT 0001213900-24-043497 000-56582 24949681 34 1372561 1 1
2024-04-01 10-K ANNUAL REPORT 0001213900-24-028690 000-56582 24808946 34 2065633 1 1
2023-11-30 3 xslF345X02/ownership.xml 0001213900-23-091524 2864
2023-11-30 3 xslF345X02/ownership.xml 0001213900-23-091519 3963
2023-11-20 UPLOAD filename1.pdf 0000000000-23-012674 39831
2023-11-14 10-Q QUARTERLY REPORT 0001213900-23-087033 000-56582 231407364 34 1349921 1 1
2023-10-06 CORRESP filename1.htm 0001213900-23-081223 47655
2023-10-06 10-12G/A AMENDMENT NO. 1 TO FORM 10-12G 0001213900-23-081214 000-56582 231315004 34 299348
2023-09-07 UPLOAD filename1.pdf 0000000000-23-009872 51271
2023-08-10 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES 0001213900-23-065705 000-56582 231160696 34 437503

Latest XBRL company facts

One latest value per concept from companyfacts (182 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 27.64M 2026-11-13 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 127,377 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 362,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 204,025 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023285
us-gaap AccruedInsuranceCurrentAndNoncurrent Accrued Insurance USD 204,025 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023285
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 410,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 23,194 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap AccruedPayrollTaxesCurrentAndNoncurrent Accrued Payroll Taxes USD 15,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 67,925 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 214,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 32,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 28.74M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -398,116 2025-09-29 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.35M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap Assets Assets USD 19.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap AssetsCurrent Assets, Current USD 17.90M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap Cash Cash USD 18,220 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044348
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 17.79M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 17.79M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -27,293 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 9.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 27.64M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 27.64M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 20,000 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 2,500 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 30,000 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023678
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 79,679 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028690
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 79,613 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028690
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 726,149 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 712,747 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 80,517 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004263
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5,130 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 3,127 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004263
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 6,879 2023-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004263
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 2,713 2024-12-31 8-K 2025-10-06 0001493152-25-016939
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 726,149 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap Depreciation Depreciation USD 32,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 32,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.189 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.233 2024-01-01 2024-12-31 8-K 2025-10-06 0001493152-25-016939
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.082 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.047 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.233 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 365,724 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.07M 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043497
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 150,000 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap Goodwill Goodwill USD 26,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 58 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004263
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 596,586 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -664,271 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 944 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 260,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -147,108 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 279,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 124,086 2025-01-01 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 6,500 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 79,259 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028690
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 284,404 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 129,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -161,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 21,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap InterestExpenseDebt Interest Expense, Debt USD 16,364 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 16,364 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap InvestmentCompanyFeePaidIndirectly Investment Company, Fee Paid Indirectly USD 800 2025-01-01 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LeaseCost Lease, Cost USD 78,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LegalFees Legal Fees USD 94,351 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 368,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 182,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 141,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap Liabilities Liabilities USD 1.17M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 19.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LiabilitiesCurrent Liabilities, Current USD 947,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.12 2024-10-28 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 14.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 79,259 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028690
us-gaap NoninterestExpenseDirectorsFees Noninterest Expense Directors Fees USD 6,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap NotesPayable Notes Payable USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap NotesPayableCurrent Notes Payable, Current USD 3,140 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingExpenses Operating Expenses USD 7.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeaseCost Operating Lease, Cost USD 78,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 335,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 157,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 178,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeasePayments Operating Lease, Payments USD 50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 329,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.097 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 2.11M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 14,652 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 21,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OtherAssets Other Assets USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap OtherExpenses Other Expenses USD 71,519 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 3,140 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 150,000 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 25,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-05 0001493152-26-036061
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PaymentsForRepurchaseOfOtherEquity Payments for Repurchase of Other Equity USD 3,140 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap PaymentsForRepurchaseOfPrivatePlacement Payments for Repurchase of Private Placement USD 1.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.83M 2025-10-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.15M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 108,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 500 2022-03-10 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028690
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 16.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.70M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 20 2025-01-01 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 52,092 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0001013762-25-004263
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 131,655 2024-10-01 2024-10-31 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap ProfessionalFees Professional Fees USD 496,084 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 83,937 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028690
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 349,218 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 4,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -10.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 376,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 4.25M 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 4.86 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.606 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 822,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 365,833 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.88M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.63 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 800,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 297,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.18 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap ShortTermBorrowings Short-term Debt USD 20,000 2025-05-31 2025 Q2 10-Q 2025-08-07 0001213900-25-073079
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 18.53M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap StockIssued1 Stock Issued USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 29,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 2.31M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 14.82M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 155 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-05 0001493152-26-036061
us-gaap TravelAndEntertainmentExpense Travel and Entertainment Expense USD 2,471 2025-01-01 2025-06-30 8-K 2025-10-06 0001493152-25-016939
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2024-12-31 8-K 2025-10-06 0001493152-25-016939
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 721,030 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014270
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 21.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 21.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051777
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 4.35M 2024-01-01 2024-06-30 8-K 2025-10-06 0001493152-25-016939

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →